CMC Biologics has successfully manufactured more than 120 biological products for pre-clinical studies through commercial approvals. Our U.S. facilities in Berkeley, CA and Seattle, WA, and our European facility in Copenhagen, Denmark, offer multiple cGMP manufacturing lines and a variety of scales for mammalian cell culture and microbial fermentation.
The innovative design of our state-of-the art facilities allows for capacity and technological flexibility, while ensuring compliance with the strict biopharmaceutical regulations required for cGMP operations. Our dedicated and experienced technical teams are committed to helping each client meet its clinical and commercial goals.
Quality matters — to patients, regulatory authorities and our clients. CMC Biologics’ quality organization provides a comprehensive suite of Quality Assurance (QA) and Quality Control (QC) services. Highly trained Quality Units maintain strict quality systems at each of our manufacturing facilities to support our cGMP manufacturing efforts and to ensure compliance with all regulatory requirements. Our facilities in the United States and Europe have been issued E.U. commercial cGMP certificates.
Our U.S. site is commercially approved by the U.S. Food and Drug Administration (FDA) for commercial cGMP production of a protein therapeutic product. The site also recently completed a successful pre-approval inspection (PAI) for a second product. In addition, our Copenhagen facility completed successful pre-approval inspections by FDA and the European Medical Authorities in 2015 and is awaiting approval of this product.